Invention Grant
- Patent Title: Method for use of homopiperazinium compounds in the treatment of cancer
-
Application No.: US15921138Application Date: 2018-03-14
-
Publication No.: US10507212B2Publication Date: 2019-12-17
- Inventor: Yvon Cormier , Evelyne Israel-Assayag
- Applicant: UNIVERSITÉ LAVAL
- Applicant Address: CA Québec
- Assignee: UNIVERSITÉ LAVAL
- Current Assignee: UNIVERSITÉ LAVAL
- Current Assignee Address: CA Québec
- Agency: Buchanan Ingersoll & Rooney P.C.
- Main IPC: A61K31/551
- IPC: A61K31/551 ; A61K31/435 ; A61K31/44 ; C07D243/08 ; C07D401/04

Abstract:
A method for treating cancer including administering to a patient in need thereof an effective amount of a compound having the formula: wherein R1, R2, Ya, Xa, and J− are as defined herein, and may be where R1 and R2 are independently selected from methyl, ethyl, n-propyl, or i-propyl; Xa is N or CH; Ya is hydrogen or independently selected from halogen, cyano, hydroxyl, alkyl of 1 to 6 carbon atoms, alkoxy of 1 to 6 carbon atoms, heteroaryl of 6 members and aryl; n is 1 or 2; wherein J− is fluoride, chloride, bromide, iodide, acetate, sulfate or sulfonate such as tosylate, mesylate, besylate.
Public/Granted literature
- US20180235978A1 METHOD FOR USE OF HOMOPIPERAZINIUM COMPOUNDS IN THE TREATMENT OF CANCER Public/Granted day:2018-08-23
Information query